207 related articles for article (PubMed ID: 26112439)
1. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
[TBL] [Abstract][Full Text] [Related]
2. Engineering Antibody Reactivity for Efficient Derivatization to Generate Na
Biswas K; Nixey TE; Murray JK; Falsey JR; Yin L; Liu H; Gingras J; Hall BE; Herberich B; Holder JR; Li H; Ligutti J; Lin MJ; Liu D; Soriano BD; Soto M; Tran L; Tegley CM; Zou A; Gunasekaran K; Moyer BD; Doherty L; Miranda LP
ACS Chem Biol; 2017 Sep; 12(9):2427-2435. PubMed ID: 28800217
[TBL] [Abstract][Full Text] [Related]
3. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Tarantula Venom-Derived Na
Wu B; Murray JK; Andrews KL; Sham K; Long J; Aral J; Ligutti J; Amagasu S; Liu D; Zou A; Min X; Wang Z; Ilch CP; Kornecook TJ; Lin MJ; Be X; Miranda LP; Moyer BD; Biswas K
J Med Chem; 2018 Nov; 61(21):9500-9512. PubMed ID: 30346167
[TBL] [Abstract][Full Text] [Related]
6. Engineering Na
Murray JK; Wu B; Tegley CM; Nixey TE; Falsey JR; Herberich B; Yin L; Sham K; Long J; Aral J; Cheng Y; Netirojjanakul C; Doherty L; Glaus C; Ikotun T; Li H; Tran L; Soto M; Salimi-Moosavi H; Ligutti J; Amagasu S; Andrews KL; Be X; Lin MJ; Foti RS; Ilch CP; Youngblood B; Kornecook TJ; Karow M; Walker KW; Moyer BD; Biswas K; Miranda LP
ACS Chem Biol; 2019 Apr; 14(4):806-818. PubMed ID: 30875193
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
Tran HNT; Tran P; Deuis JR; Agwa AJ; Zhang AH; Vetter I; Schroeder CI
Bioconjug Chem; 2020 Jan; 31(1):64-73. PubMed ID: 31790574
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
[TBL] [Abstract][Full Text] [Related]
9. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP
J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998
[TBL] [Abstract][Full Text] [Related]
10. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
11. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Sun S; Cohen CJ; Dehnhardt CM
Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
[TBL] [Abstract][Full Text] [Related]
14. The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Na
Wright ZVF; McCarthy S; Dickman R; Reyes FE; Sanchez-Martinez S; Cryar A; Kilford I; Hall A; Takle AK; Topf M; Gonen T; Thalassinos K; Tabor AB
J Am Chem Soc; 2017 Sep; 139(37):13063-13075. PubMed ID: 28880078
[TBL] [Abstract][Full Text] [Related]
15. Na
Xu B; Zhang R; Zhang M; Chen D; Zhang Q; Zhang N; Shi Y; Hu X; Li N; Fang Q
J Pain; 2023 May; 24(5):840-859. PubMed ID: 36586660
[TBL] [Abstract][Full Text] [Related]
16. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
17. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
18. Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena.
Revell JD; Lund PE; Linley JE; Metcalfe J; Burmeister N; Sridharan S; Jones C; Jermutus L; Bednarek MA
Peptides; 2013 Jun; 44():40-6. PubMed ID: 23523779
[TBL] [Abstract][Full Text] [Related]
19. Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels.
Park JH; Carlin KP; Wu G; Ilyin VI; Musza LL; Blake PR; Kyle DJ
J Med Chem; 2014 Aug; 57(15):6623-31. PubMed ID: 25026046
[TBL] [Abstract][Full Text] [Related]
20. Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.
Flinspach M; Xu Q; Piekarz AD; Fellows R; Hagan R; Gibbs A; Liu Y; Neff RA; Freedman J; Eckert WA; Zhou M; Bonesteel R; Pennington MW; Eddinger KA; Yaksh TL; Hunter M; Swanson RV; Wickenden AD
Sci Rep; 2017 Jan; 7():39662. PubMed ID: 28045073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
